A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants
一项针对健康、接种过卡介苗的婴儿开展的双盲、随机、安慰剂对照、剂量探索性试验，研究新型结核病疫苗 AERAS-402（一种腺病毒载体融合蛋白）的疗效。
期刊:
影响因子:
doi:10.1016/j.vaccine.2015.03.070
Tameris, M; Hokey, D A; Nduba, V; Sacarlal, J; Laher, F; Kiringa, G; Gondo, K; Lazarus, E M; Gray, G E; Nachman, S; Mahomed, H; Downing, K; Abel, B; Scriba, T J; McClain, J B; Pau, M G; Hendriks, J; Dheenadhayalan, V; Ishmukhamedov, S; Luabeya, A K K; Geldenhuys, H; Shepherd, B; Blatner, G; Cardenas, V; Walker, R; Hanekom, W A; Sadoff, J; Douoguih, M; Barker, L; Hatherill, M
